Avidity Biosciences Cash from Operations (TTM) Insights

Avidity Biosciences Inc (RNA)

24.16 +1.43 (+6.29%) USD | NASDAQ | Apr 22, 16:00

24.17 +0.01 (+0.04%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-119.06M
September 30, 2023	-174.75M
June 30, 2023	-169.92M
March 31, 2023	-155.66M
December 31, 2022	-136.27M
September 30, 2022	-123.29M
June 30, 2022	-112.12M
March 31, 2022	-104.71M
December 31, 2021	-94.81M

Date	Value
September 30, 2021	-81.67M
June 30, 2021	-70.00M
March 31, 2021	-49.66M
December 31, 2020	-37.12M
September 30, 2020	-29.06M
June 30, 2020	-25.84M
March 31, 2020	-2.564M
December 31, 2019	2.49M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-174.75M

Minimum

Sep 2023

2.49M

Maximum

Dec 2019

-87.30M

Average

-94.81M

Median

Dec 2021

Cash from Operations (TTM) Benchmarks